![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, May 25, 2016 11:15:53 AM
1) Dr. Arthur L. J. Rosenthal, Ph.D., also known as Art serves as Advisor of Arch Therapeutics, Inc. He served as a Vice President of Research and Development at Johnson & Johnson Medical, Inc., from April 1990 to January 1994, and was in charge of worldwide research, development, regulatory, and clinical affairs for the JJMI Division—Google Arthur L. J. Rosenthal Ph.D. to see his impressive background.
2) retired former COO of Arch William Cotter was one of key officers of Closure Medical Corporation which was sold to JNJ in 2005.See Arch press release Arch Therapeutics Appoints Senior Management Team Members CAMBRIDGE, MA -- (Marketwired) -- 07/08/13
Johnson & Johnson and CLOSURE Medical Corporation Announce Acquisition Agreement
Acquisition to Strengthen Presence in Topical Adhesives and Surgical Sealants
NEW BRUNSWICK, N.J. and RALEIGH, N.C., March 4, 2005
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM